BerandaALKS • NASDAQ
add
Alkermes Plc
$28,45
Setelah Jam Perdagangan Normal:(0,00%)0,00
$28,45
Tutup: 9 Mar, 16.02.45 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$28,63
Rentang hari
$27,96 - $28,89
Rentang tahun
$25,17 - $36,32
Kapitalisasi pasar
4,74Â M USD
Volume Rata-Rata
2,00Â jt
Rasio P/E
19,87
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 384,55Â jt | -10,57% |
Biaya operasional | 280,23Â jt | 36,58% |
Penghasilan bersih | 49,34Â jt | -66,32% |
Margin laba bersih | 12,83 | -62,34% |
Penghasilan per saham | 0,44 | -58,47% |
EBITDA | 61,95Â jt | -63,46% |
Tarif pajak efektif | 18,28% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 588,22Â jt | -21,75% |
Total aset | 2,49Â M | 20,99% |
Total liabilitas | 667,70Â jt | 13,06% |
Total ekuitas | 1,82 M | — |
Saham yang beredar | 166,65 jt | — |
Harga terhadap nilai buku | 2,61 | — |
Tingkat pengembalian aset | 6,03% | — |
Tingkat pengembalian modal | 7,86% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 49,34Â jt | -66,32% |
Kas dari operasi | 170,07Â jt | -10,68% |
Kas dari investasi | 322,35Â jt | 2.423,21% |
Kas dari pembiayaan | 10,91Â jt | 103,87% |
Perubahan kas bersih | 503,33Â jt | 578,69% |
Arus kas bebas | -582,65Â jt | -574,85% |
Tentang
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Didirikan
1987
Situs
Karyawan
2.050
